Evis Daci

1.6k total citations
14 papers, 414 citations indexed

About

Evis Daci is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology. According to data from OpenAlex, Evis Daci has authored 14 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Evis Daci's work include Protease and Inhibitor Mechanisms (5 papers), Bone health and treatments (4 papers) and Bone Metabolism and Diseases (4 papers). Evis Daci is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Bone health and treatments (4 papers) and Bone Metabolism and Diseases (4 papers). Evis Daci collaborates with scholars based in Belgium, United States and Netherlands. Evis Daci's co-authors include Geert Carmeliet, Roger Bouillon, Annemieke Verstuyf, Sophie Van Cromphaut, Siegfried Segaert, Nobuyuki Udagawa, T. John Martin, Karen Moermans, R. Bouillon and Vincent Everts and has published in prestigious journals such as Journal of Bone and Mineral Research, Bone and Osteoporosis International.

In The Last Decade

Evis Daci

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evis Daci Belgium	8	149	101	96	95	88	14	414
Masaaki Shima Japan	14	164 1.1×	98 1.0×	149 1.6×	55 0.6×	83 0.9×	22	542
Hirofumi Kurose Japan	13	142 1.0×	196 1.9×	75 0.8×	50 0.5×	34 0.4×	44	481
Mila Jhamai Netherlands	10	250 1.7×	111 1.1×	204 2.1×	47 0.5×	174 2.0×	13	612
Seth Arum United States	8	266 1.8×	75 0.7×	85 0.9×	22 0.2×	44 0.5×	24	496
Zhengju Fu China	10	158 1.1×	73 0.7×	56 0.6×	63 0.7×	48 0.5×	14	414
Pablo Román‐García Spain	14	149 1.0×	106 1.0×	138 1.4×	35 0.4×	120 1.4×	19	700
Jody McLean United States	6	219 1.5×	66 0.7×	30 0.3×	46 0.5×	70 0.8×	9	531
Anaïs Mozar France	14	163 1.1×	58 0.6×	51 0.5×	22 0.2×	43 0.5×	16	504
O. Wang China	10	98 0.7×	85 0.8×	60 0.6×	28 0.3×	141 1.6×	19	372
Miia Suuriniemi United States	15	236 1.6×	196 1.9×	138 1.4×	114 1.2×	248 2.8×	18	847

Countries citing papers authored by Evis Daci

Since Specialization

Citations

This map shows the geographic impact of Evis Daci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evis Daci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evis Daci more than expected).

Fields of papers citing papers by Evis Daci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evis Daci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evis Daci. The network helps show where Evis Daci may publish in the future.

Co-authorship network of co-authors of Evis Daci

This figure shows the co-authorship network connecting the top 25 collaborators of Evis Daci. A scholar is included among the top collaborators of Evis Daci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evis Daci. Evis Daci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gaal, Luc Van, Michel P. Hermans, Evis Daci, et al.. (2019). Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study. Diabetes Therapy. 10(3). 965–979. 2 indexed citations

Hermans, Michel P., Luc Van Gaal, Evis Daci, et al.. (2016). Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study). Primary care diabetes. 10(6). 425–433. 6 indexed citations

Hostè, J., Evis Daci, & Chantal Mathieu. (2014). Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE):post-hocsubanalysis of the Belgian data. Acta Clinica Belgica. 69(3). 171–176. 3 indexed citations

Devogelaer, J.-P., Piet Geusens, Evis Daci, et al.. (2013). Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid. Calcified Tissue International. 94(3). 311–318. 14 indexed citations

Daci, Evis, K. Allewaert, Kris Denhaerynck, et al.. (2013). Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study). Annals of Dermatology. 25(1). 28–28. 5 indexed citations

Everts, Vincent, Evis Daci, Wikky Tigchelaar‐Gutter, et al.. (2008). Plasminogen activators are involved in the degradation of bone by osteoclasts. Bone. 43(5). 915–920. 15 indexed citations

Carmeliet, Geert, Sophie Van Cromphaut, Evis Daci, Christa Maes, & Roger Bouillon. (2003). Disorders of calcium homeostasis. Best Practice & Research Clinical Endocrinology & Metabolism. 17(4). 529–546. 42 indexed citations

Daci, Evis, Vincent Everts, Sophie Torrekens, et al.. (2003). Increased Bone Formation in Mice Lacking Plasminogen Activators. Journal of Bone and Mineral Research. 18(7). 1167–1176. 63 indexed citations

Daci, Evis, Sophie Van Cromphaut, & Roger Bouillon. (2002). Mechanisms Influencing Bone Metabolism in Chronic Illness. Hormone Research in Paediatrics. 58(Suppl. 1). 44–51. 40 indexed citations

10.

Daci, Evis, Annemieke Verstuyf, Karen Moermans, Roger Bouillon, & Geert Carmeliet. (2000). Bone resorption induced by 1α,25 dihydroxyvitamin D3 in vivo is not altered by inactivation of the plasminogen activator inhibitor 1. Bone. 27(1). 97–102. 2 indexed citations

11.

Daci, Evis, Annemieke Verstuyf, Karen Moermans, R. Bouillon, & Geert Carmeliet. (2000). Mice Lacking the Plasminogen Activator Inhibitor 1 Are Protected from Trabecular Bone Loss Induced by Estrogen Deficiency. Journal of Bone and Mineral Research. 15(8). 1510–1516. 63 indexed citations

12.

Daci, Evis, Nobuyuki Udagawa, T. John Martin, Roger Bouillon, & Geert Carmeliet. (1999). The Role of the Plasminogen System in Bone Resorption In Vitro. Journal of Bone and Mineral Research. 14(6). 946–952. 76 indexed citations

13.

Bouillon, Roger, Geert Carmeliet, Evis Daci, Siegfried Segaert, & Annemieke Verstuyf. (1998). Vitamin D Metabolism and Action. Osteoporosis International. 8(S2). S13–S19. 81 indexed citations

14.

Bouillon, R., Evis Daci, Geert Carmeliet, M Bex, & Susan M. Webb. (1998). Pituitary tumours and bone. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact